PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1777632
PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1777632
Global Transcranial Magnetic Stimulation Systems Market to Reach US$1.9 Billion by 2030
The global market for Transcranial Magnetic Stimulation Systems estimated at US$1.3 Billion in the year 2024, is expected to reach US$1.9 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Deep Transcranial Magnetic Stimulation, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Repetitive Transcranial Magnetic Stimulation segment is estimated at 9.3% CAGR over the analysis period.
The U.S. Market is Estimated at US$354.9 Million While China is Forecast to Grow at 10.5% CAGR
The Transcranial Magnetic Stimulation Systems market in the U.S. is estimated at US$354.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$397.8 Million by the year 2030 trailing a CAGR of 10.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 6.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.
Transcranial Magnetic Stimulation System Market Trends & Drivers Summarized
How Is Transcranial Magnetic Stimulation (TMS) Revolutionizing Neurological and Psychiatric Treatment?
Transcranial Magnetic Stimulation (TMS) is emerging as a groundbreaking non-invasive therapy for neurological and psychiatric disorders, particularly major depressive disorder (MDD), anxiety, and treatment-resistant depression. By using magnetic fields to stimulate nerve cells in the brain, TMS offers an alternative to pharmacological interventions, providing relief to patients who do not respond to antidepressants. The growing acceptance of TMS as a treatment for conditions such as obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and chronic pain is driving market expansion. The integration of AI-driven precision targeting and personalized neuromodulation techniques is further enhancing treatment outcomes. However, challenges such as high treatment costs, accessibility issues, and the need for skilled professionals remain barriers to widespread adoption. As neuroscience advances, how will TMS continue to shape the future of mental health and neurorehabilitation?
What Technological Innovations Are Advancing Transcranial Magnetic Stimulation?
Recent innovations in TMS focus on improving targeting precision, treatment efficiency, and patient comfort. AI-driven brain mapping is enhancing the accuracy of magnetic field application, optimizing stimulation sites for personalized treatment. Deep TMS technology, which penetrates deeper into brain regions, is improving outcomes for conditions such as bipolar disorder and chronic pain. Portable and home-use TMS devices are in development, expanding treatment accessibility beyond clinical settings. Additionally, integration with real-time EEG (electroencephalography) monitoring is allowing for adaptive neuromodulation, refining the therapeutic impact of TMS sessions.
Why Is the Demand for Transcranial Magnetic Stimulation Increasing?
The rising prevalence of mental health disorders, growing patient preference for non-invasive therapies, and increasing regulatory approvals for new indications are driving demand for TMS. The stigma around antidepressant dependency and concerns about side effects are further encouraging patients to seek alternative treatment modalities. Additionally, research into the application of TMS for neurodegenerative diseases such as Alzheimer's and Parkinson's is expanding its clinical potential.
What Factors Are Driving the Growth of the TMS Market?
The market is growing due to advancements in AI-assisted neurostimulation, increasing awareness of alternative mental health treatments, rising investment in neuromodulation research, and expanding applications beyond depression treatment. As TMS becomes more accessible and integrated with digital health solutions, its role in neurological and psychiatric care is expected to expand significantly.
SCOPE OF STUDY:
The report analyzes the Transcranial Magnetic Stimulation Systems market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Type (Deep Transcranial Magnetic Stimulation, Repetitive Transcranial Magnetic Stimulation, Others); Application (Alzheimer's Disease, Depression, Parkinson's Disease, Epilepsy, Others)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 43 Featured) -
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.